论文部分内容阅读
１９８１年１月至１９９２年１２月间，我们共治疗食管贲门癌３４６７例，其中３５岁以下青年食管贲门癌１８１例，占同期手术病例的５．２４％（１８１／３４６７）。手术切除率９０％，并发症发生率６．８％（１１／１８１），手术死亡率１．１％（２／１８１）。术后１、３、５、１０年生存率分别为９８．５％、３９．６％、２７．５％、１２．３％，综合治疗远期生存率，３、５、１０年为４２．３％、３０．６％、１３．１％。本文提示：提高远期生存率的关键在于早期确诊，尽早治疗及术后放疗、化疗的配合。
Between January 1981 and December 1992, we treated a total of 3,467 cases of esophageal and cardiac cancers, of which 181 were esophageal and cardiac cancers among young people under the age of 35, accounting for 5.24% (181/3467) of the same period. The surgical resection rate was 90%, the complication rate was 6.8% (11/181), and the operative mortality rate was 1.1% (2/181). The survival rates at 1, 3, 5, and 10 years after surgery were 98.5%, 39.6%, 27.5%, and 12.3%, respectively, and the overall survival rate was in the long-term, 3, 5, and 10 years. 3%, 30.6%, 13.1%. This article suggests that the key to improving long-term survival is early diagnosis, early treatment and postoperative radiotherapy and chemotherapy.